Colgate-Palmolive (NYSE:CL) Shares Sold by Slocum Gordon & Co LLP

Slocum Gordon & Co LLP trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.7% during the second quarter, HoldingsChannel reports. The institutional investor owned 27,616 shares of the company’s stock after selling 200 shares during the quarter. Colgate-Palmolive accounts for about 2.0% of Slocum Gordon & Co LLP’s investment portfolio, making the stock its 18th largest holding. Slocum Gordon & Co LLP’s holdings in Colgate-Palmolive were worth $2,680,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $25,000. Union Savings Bank raised its stake in shares of Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. PSI Advisors LLC raised its stake in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares during the period. Continuum Advisory LLC raised its stake in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares during the period. Finally, Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently issued reports on CL shares. Stifel Nicolaus lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. TD Cowen lifted their price target on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Barclays lifted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Finally, Bank of America lifted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $102.53.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 over the last 90 days. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of CL opened at $108.79 on Friday. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $109.30. The company has a market cap of $89.26 billion, a price-to-earnings ratio of 34.34, a price-to-earnings-growth ratio of 3.73 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a fifty day moving average of $100.86 and a 200-day moving average of $94.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.84%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s payout ratio is currently 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.